Trial Profile
Effectiveness of human normal immunoglobulin ( IGHN ) in toxic shock ( staphylococcal and streptococcal ) : Pediatric feasibility study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2019
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Septic shock
- Focus Therapeutic Use
- Acronyms IGHN
- 05 May 2019 Status changed from recruiting to completed.
- 07 Aug 2015 New trial record